Clinical sample analyses further indicated that lower TFAM expression correlates with poor prognosis in patients with renal cell carcinoma, glioma, and colorectal cancer (https://www.proteinatlas.org/ENSG00000108064-TFAM/cancer). The gene discussed is TFAM; the disease is hereditary clear cell renal cell carcinoma.